PMID- 37553950 OWN - NLM STAT- MEDLINE DCOM- 20231010 LR - 20231010 IS - 1945-8932 (Electronic) IS - 1945-8932 (Linking) VI - 37 IP - 6 DP - 2023 Nov TI - Glucocorticoid-Induced Transcript 1(GLCCI1) SNP rs37937 Is Associated With the Risk of Developing Allergic Rhinitis and the Response to Intranasal Corticosteroids in a Chinese Han Population. PG - 751-757 LID - 10.1177/19458924231193156 [doi] AB - BACKGROUND: Evidence has shown that glucocorticoid-induced transcript 1 (GLCCI1) single nucleotide polymorphism (SNP) rs37937 is associated with asthma. OBJECTIVES: The objective of this study was to investigate whether the GLCCI1 SNP rs37937 is a risk factor for allergic rhinitis (AR) in a Chinese Han population. METHODS: A total of 220 individuals including 109 AR patients and 111 healthy subjects were included. The genotyping of GLCCI1 rs37973 was performed by the SNaPshot method. The correlations of rs37973 polymorphism, AR risk, and clinical characteristics were further analyzed, as well as the treatment response to intranasal corticosteroids (INCS) in AR patients of different genotypes. RESULTS: Three GLCCI1 rs37973 SNP genotypes were identified in both AR patients and healthy subjects. Significant association between rs37973 polymorphism and AR under allele model, dominant model, heterozygote model, and homozygote model were shown. The A allele frequency of SNP rs37973 in AR was significantly higher than that in controls. The serum total immunoglobulin E (IgE) in AR patients of AA genotype was significantly higher than in patients of GA and GG genotype, and the serum total IgE in GA genotype was significantly higher than in GG genotype. Interestingly, after 4 weeks of INCS treatment for AR patients, the improvement of the nasal itching score, sneezing score, runny nose score, total nasal symptom score, and visual analog scale score of the GG genotype were worse than the AA or GA genotype. CONCLUSION: The GLCCI1 rs37937 polymorphism is associated with the risk of developing AR and the response to INCS treatment in the Chinese Han population. FAU - Liang, Xu AU - Liang X AD - Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, China. RINGGOLD: 531675 FAU - Jin, Peng AU - Jin P AD - Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, China. RINGGOLD: 531675 FAU - Zhan, Changcui AU - Zhan C AD - Department of Otolaryngology, Dongping County People's Hospital, Taian, China. FAU - Zhao, Li AU - Zhao L AUID- ORCID: 0000-0003-1777-0493 AD - Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, China. RINGGOLD: 531675 FAU - Zi, Xiaoxue AU - Zi X AD - Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, China. RINGGOLD: 531675 FAU - Zhi, Lili AU - Zhi L AD - Department of Allergy, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China. RINGGOLD: 66310. RINGGOLD: 66310 FAU - Yu, Kena AU - Yu K AUID- ORCID: 0000-0003-1638-7468 AD - Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, China. RINGGOLD: 531675 LA - eng PT - Journal Article DEP - 20230808 PL - United States TA - Am J Rhinol Allergy JT - American journal of rhinology & allergy JID - 101490775 RN - 0 (Glucocorticoids) RN - 37341-29-0 (Immunoglobulin E) RN - 0 (Receptors, Glucocorticoid) RN - 0 (GLCCI1 protein, human) RN - Han Chinese people SB - IM MH - Humans MH - East Asian People MH - Genotype MH - *Glucocorticoids/administration & dosage/therapeutic use MH - Immunoglobulin E/genetics/immunology MH - Polymorphism, Single Nucleotide MH - *Receptors, Glucocorticoid/genetics MH - *Rhinitis, Allergic/drug therapy/genetics/immunology MH - Administration, Intranasal MH - Risk Factors OTO - NOTNLM OT - Chinese Han population OT - GLCCI1 OT - IgE OT - allele OT - allergic rhinitis OT - clinical characteristics OT - gene OT - genotype OT - intranasal corticosteroids OT - single nucleotide polymorphism COIS- Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2023/08/09 06:43 MHDA- 2023/10/04 06:43 CRDT- 2023/08/09 02:33 PHST- 2023/10/04 06:43 [medline] PHST- 2023/08/09 06:43 [pubmed] PHST- 2023/08/09 02:33 [entrez] AID - 10.1177/19458924231193156 [doi] PST - ppublish SO - Am J Rhinol Allergy. 2023 Nov;37(6):751-757. doi: 10.1177/19458924231193156. Epub 2023 Aug 8.